Medical Condition News

RSS

Cardiff develops simple and effective wound test that could save NHS millions

Scientists in Cardiff are developing a simple but effective test to predict whether chronic wounds will respond to conventional treatment - which could save the NHS tens of millions of pounds annually.

20 Sep 2011

Henry Ford Hospital performs DBS procedure inside iMRI to treat Parkinson's

Henry Ford Hospital became the third hospital in the United States to perform a Deep Brain Stimulation (DBS) procedure inside an Intraoperative Magnetic Resonance Imaging scanner, or iMRI.

20 Sep 2011

Global trade negotiations must consider inequalities in access to medicines

Some of the issues to be addressed at the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York "are controversial, including those relating to intellectual property rights for new medicines, diagnostics and medical devices," James Love, director of Knowledge Ecology International, writes in an Al Jazeera opinion piece.

20 Sep 2011

New York Times examines possible entry into global market of generic drugs for NCDs

The New York Times describes how, as the U.N. begins its meeting on non-communicable diseases (NCDs), Chinese and Indian generic drug makers "say they are on the verge of selling cheaper copies" of costly biotech medications used to treat cancers, diabetes, arthritis and other chronic illnesses.

20 Sep 2011

WHO, WEF reports examine cost of treating and preventing, economic burden of NCDs

Low-income countries "could introduce measures to prevent and treat millions of cases of cancer, heart disease, diabetes and lung disease for a little as $1.20 per person per year, the World Health Organization (WHO) said on Sunday" in a report released on the eve of the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York, Reuters reports.

20 Sep 2011

BIOTRONIK completes enrollment in Passeo-18 Lux DEB catheter clinical study for PAD

BIOTRONIK, a leading European manufacturer of therapy solutions for vascular intervention, announced the completion of enrollment in the BIOLUX P-I - a clinical study investigating the use of a drug-eluting balloon (DEB) catheter, a promising new approach to treating disease in the more challenging peripheral vascular anatomy.

20 Sep 2011

Yawning could regulate brain temperature

A study led by Andrew Gallup, a postdoctoral research associate in Princeton University's Department of Ecology and Evolutionary Biology, is the first involving humans to show that yawning frequency varies with the season and that people are less likely to yawn when the heat outdoors exceeds body temperature.

20 Sep 2011

Regular exercise also increases mitochondrial numbers in brain cells

Researchers have long known that regular exercise increases the number of organelles called mitochondria in muscle cells. Since mitochondria are responsible for generating energy, this numerical boost is thought to underlie many of the positive physical effects of exercise, such as increased strength or endurance. Exercise also has a number of positive mental effects, such as relieving depression and improving memory.

20 Sep 2011

NCD draft declaration lacks specific targets, calls for nations to adopt recommendations for reducing chronic disease deaths

"World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable 'lifestyle' diseases," including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), "amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries," the Guardian reports.

20 Sep 2011

Researchers identify 16 new genetic variations that affect blood pressure

High blood pressure is a well-known risk factor for heart disease. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have participated in an international study of 200,000 Europeans which has identified 16 new genetic variations that affect blood pressure. The discovery, presented in Nature, is an important step towards better diagnostics and treatment.

20 Sep 2011

People with diabetes more likely to develop dementia

People with diabetes appear to be at a significantly increased risk of developing dementia, according to a study published in the September 20, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

20 Sep 2011

SK Biopharmaceuticals, Mayo Clinic collaborate to develop new treatments for ALS

Mayo Clinic's campus in Florida has entered into a collaborative and sponsored research agreement with SK Biopharmaceuticals of Seoul, South Korea, with the goal of developing new treatments for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. The collaboration marks a new approach to combating a disease that has proved difficult to treat in recent clinical trials.

20 Sep 2011

Common misconceptions about Alzheimer's disease

Alzheimer's disease, the most common form of dementia, continues to be an ongoing battle for millions of Americans. With an estimated 5.4 million Americans living with the disease and an annual cost of $183 billion, Dr. Gustavo C. Roman, director of the Nantz National Alzheimer Center at the Methodist Neurological Institute, addresses some common misconceptions about this devastating disease.

20 Sep 2011

Top-line data from Santarus' budesonide MMX extended use study on ulcerative colitis

Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.

20 Sep 2011

UNC researchers reveal genetic underpinnings of Foxp3-expressing regulatory T cells

Within the immune system, a subtle balance exists between the cells that destroy alien pathogens and those that preserve the body's own tissues. When the balance gets out of whack, the cells that normally target viruses or bacteria can go astray, attacking innocent cells and causing autoimmune and inflammatory disease.

20 Sep 2011

New UCSB technology can identify cancerous prostate cells

A team of researchers at UC Santa Barbara has developed a breakthrough technology that can be used to discriminate cancerous prostate cells in bodily fluids from those that are healthy.

20 Sep 2011

Neurocritical Care Society announces comprehensive set of guidelines on brain aneurysms

The Neurocritical Care Society is releasing a comprehensive set of guidelines this week to guide physicians and hospitals on how to optimally care for patient's ruptured brain aneurysms. One of the strongest recommendations is that all patients receive specialized care at high-volume stroke centers that treat at least 60 cases per year.

20 Sep 2011

ACR launches Simple Tasks campaign to raise awareness on rheumatic diseases

The American College of Rheumatology has launched its Simple Tasks campaign. The initiative aims to raise awareness of the severe impact of rheumatic diseases - such as rheumatoid arthritis, lupus and gout - on the U.S. population and to highlight the importance of rheumatologists in the diagnosis and treatment of these diseases.

20 Sep 2011

UNC researchers develop technique that can observe cellular intricacies of CF

When researchers discovered the primary genetic defect that causes cystic fibrosis (CF) back in 1989, they opened up a new realm of research into treatment and a cure for the disease. Since then, scientists have been able to clone the defective gene and study its effects in animals. Now researchers at the University of North Carolina at Chapel Hill have developed a technique for observing the defects at work in human tissue donated by patients with CF.

20 Sep 2011

Calgary researchers discover new class of anti-inflammatory agents

By using a mouse model of inflammation researchers at the University of Calgary have discovered a new class of molecules that can inhibit the recruitment of some white blood cells to sites of inflammation in the body.

20 Sep 2011

Medical Condition News

Cardiff develops simple and effective wound test that could save NHS millions

Henry Ford Hospital performs DBS procedure inside iMRI to treat Parkinson's

Global trade negotiations must consider inequalities in access to medicines

New York Times examines possible entry into global market of generic drugs for NCDs

WHO, WEF reports examine cost of treating and preventing, economic burden of NCDs

BIOTRONIK completes enrollment in Passeo-18 Lux DEB catheter clinical study for PAD

Yawning could regulate brain temperature

Regular exercise also increases mitochondrial numbers in brain cells

NCD draft declaration lacks specific targets, calls for nations to adopt recommendations for reducing chronic disease deaths

Researchers identify 16 new genetic variations that affect blood pressure

People with diabetes more likely to develop dementia

SK Biopharmaceuticals, Mayo Clinic collaborate to develop new treatments for ALS

Common misconceptions about Alzheimer's disease

Top-line data from Santarus' budesonide MMX extended use study on ulcerative colitis

UNC researchers reveal genetic underpinnings of Foxp3-expressing regulatory T cells

New UCSB technology can identify cancerous prostate cells

Neurocritical Care Society announces comprehensive set of guidelines on brain aneurysms

ACR launches Simple Tasks campaign to raise awareness on rheumatic diseases

UNC researchers develop technique that can observe cellular intricacies of CF

Calgary researchers discover new class of anti-inflammatory agents

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News